Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Sergio A. Giralt"'
Autor:
Mariam T. Nawas, Miriam Sanchez-Escamilla, Sean M. Devlin, Molly A. Maloy, Josel D. Ruiz, Craig S. Sauter, Sergio A. Giralt, Miguel-Angel Perales, Michael Scordo
Publikováno v:
Blood Advances. 6:5898-5907
Endothelial activation and stress index (EASIX) predicts nonrelapse mortality (NRM) when assessed before hematopoietic cell transplantation (HCT). We sought to determine whether changes in EASIX after HCT may be an informative marker of NRM. We evalu
Autor:
John L, Vaughn, Samantha, Brown, Esperanza B, Papadopoulos, Ann A, Jakubowski, Roni, Tamari, Sergio A, Giralt, Doris M, Ponce, Christina, Cho, Miguel-Angel, Perales, Brian C, Shaffer, Boglarka, Gyurkocza
Publikováno v:
Bone marrow transplantation. 57(11)
Autor:
Mariam T. Nawas, Jeong-Ok Lee, Jessica Flynn, Molly Maloy, Ann A. Jakubowski, Esperanza B. Papadopoulos, Christina Cho, Doris M. Ponce, Craig S. Sauter, Miguel-Angel Perales, Sean Devlin, Sergio A. Giralt, Hugo R. Castro-Malaspina, Roni Tamari
Publikováno v:
Bone Marrow Transplant
Allogeneic hematopoietic stem cell transplantation (Allo-HCT) remains the only curative treatment for myelofibrosis (MF). Transplantation in patients with MF is mostly done using a reduced intensity conditioning regimen with calcineurin inhibitors fo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d08f8aeb1fc5b08b3edeab7284c7eea
https://europepmc.org/articles/PMC10015419/
https://europepmc.org/articles/PMC10015419/
Autor:
Michael, Scordo, Valkal, Bhatt, Patrick, Hilden, Melody, Smith, Katie, Thoren, Christina, Cho, Gunjan L, Shah, Molly A, Maloy, Esperanza B, Papadopoulos, Ann A, Jakubowski, Scott T, Avecilla, Richard J, O'Reilly, Hugo, Castro-Malaspina, Roni, Tamari, Brian C, Shaffer, Jaap J, Boelens, Miguel-Angel, Perales, Sergio A, Giralt
Publikováno v:
Biol Blood Marrow Transplant
Antithymocyte globulin (ATG) use mitigates the risk of graft rejection and graft-versus-host disease (GVHD) after allogeneic hematopoietic cell transplantation (allo-HCT), but ATG overexposure in the setting of lymphopenia negatively affects immune r
Autor:
Seong Jin, Kim, Yao-Ting, Huang, Julia, Foldi, Yeon Joo, Lee, Molly, Maloy, Sergio A, Giralt, Ann A, Jakubowski, Genovefa A, Papanicolaou
Publikováno v:
Transplant infectious disease : an official journal of the Transplantation Society. 20(3)
BACKGROUND: Cytomegalovirus (CMV) viremia after CD34(+) selected hematopoietic stem cell transplant (HCT) often requires prolonged antiviral therapy. We report rates and outcomes of resistant CMV in a contemporary cohort of CD34(+) selected HCT recip
Autor:
Pere, Barba, Ravin, Ratan, Christina, Cho, Izaskun, Ceberio, Patrick, Hilden, Sean M, Devlin, Molly A, Maloy, Juliet N, Barker, Hugo, Castro-Malaspina, Ann A, Jakubowski, Guenther, Koehne, Esperanza B, Papadopoulos, Doris M, Ponce, Craig, Sauter, Roni, Tamari, Marcel R M, van den Brink, James W, Young, Richard J, O'Reilly, Sergio A, Giralt, Miguel-Angel, Perales
Publikováno v:
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation. 23(1)
To evaluate the association between the hematopoietic cell transplantation-comorbidity index (HCT-CI) and the recently developed age-adjusted HCT-CI (HCT-CI/age) and transplant outcomes in the setting of CD34-selected allogeneic HCT, we analyzed a ho